In Vitro Models of Parkinson's Disease

Explore Neuroprotective Effect of Compounds in Cellular Models

Parkinson’s disease, a debilitating disease caused by loss of dopaminergic nerve cells in the substantia nigra of the central nervous system resulting in the onset of symptoms such as tremor, rigidity and slowness of movement.
 
Eurofins Discovery has established three in vitro cell death models in human dopaminergic neuroblastoma cell line, SH-SY5Y that mimic different aspects of cell death reportedly seen in Parkinson’s disease.

Features